CIMG's Revenue Plummets 97% Amid Strategic Shift, Cash Dwindles
Ticker: CIMG · Form: 10-Q/A · Filed: Nov 18, 2025 · CIK: 1527613
Sentiment: bearish
Topics: 10-Q/A, Revenue Decline, Net Loss, Cash Burn, Strategic Pivot, Liquidity Risk, Convertible Notes, Private Placement, Going Concern, Emerging Growth Company
Related Tickers: CIMG
TL;DR
**CIMG's revenue cratered 97% as cash vanished, making its strategic pivot a high-stakes gamble with limited runway.**
AI Summary
CIMG Inc. (CIMG) filed a 10-Q/A for the quarter ended December 31, 2024, primarily to include omitted disclosures like Management's Discussion and Analysis, Market Risk, and Controls and Procedures. The company reported a significant decline in net revenue, falling from $965,932 in Q4 2023 to $22,853 in Q4 2024, a decrease of 97.6%. This led to a gross profit of only $15,479, down from $124,534 in the prior year. Despite the revenue drop, the net loss improved slightly to $(1,536,249) from $(2,148,611) year-over-year, largely due to reduced operating expenses, which decreased from $(2,145,642) to $(1,517,758). The company's cash and cash equivalents significantly decreased from $464,222 at September 30, 2024, to $124,715 at December 31, 2024. Total current liabilities also saw a substantial reduction from $6,238,323 to $3,640,244, primarily driven by the repayment of a short-term loan by $1,486,996 and the conversion of convertible notes into stock. CIMG completed the conversion of $1,300,000 in August Notes into common stock at a conversion price of $0.94 per share on October 31, 2024. The company also issued 3,508,769 shares through a private placement, raising $2,000,000.
Why It Matters
This filing reveals a dramatic 97.6% revenue collapse for CIMG, signaling a critical period for the company as it pivots from specialty coffee to a broader consumer food and beverage focus in Asia. While net loss narrowed, the significant reduction in cash and cash equivalents to $124,715 raises immediate liquidity concerns for investors. The successful conversion of $1,300,000 in convertible notes and a $2,000,000 private placement provided some capital, but the underlying business performance is weak. Competitors in the Asian food and beverage market, particularly those with established online platforms, will likely see CIMG's struggles as an opportunity to gain market share.
Risk Assessment
Risk Level: high — The risk level is high due to a 97.6% drop in net revenue from $965,932 to $22,853 year-over-year, indicating severe operational challenges. Cash and cash equivalents plummeted from $464,222 to $124,715, and the company explicitly states in its forward-looking statements that it expects to 'need additional capital to fund our planned operations beyond' the next three months.
Analyst Insight
Investors should exercise extreme caution and consider divesting CIMG shares given the precipitous revenue decline and precarious cash position. New investors should avoid CIMG until there is clear evidence of successful execution of its new strategy and a significant improvement in financial performance, particularly revenue generation and cash flow.
Financial Highlights
- debt To Equity
- N/A
- revenue
- $22,853
- operating Margin
- N/A
- total Assets
- N/A
- total Debt
- N/A
- net Income
- $(1,536,249)
- eps
- N/A
- gross Margin
- 7.0%
- cash Position
- $124,715
- revenue Growth
- -97.6%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Total Net Revenue | $22,853 | -97.6% |
Key Numbers
- $22,853 — Net Revenue (For the three months ended December 31, 2024, a 97.6% decrease from prior year.)
- $965,932 — Net Revenue (For the three months ended December 31, 2023.)
- $(1,536,249) — Net Loss (For the three months ended December 31, 2024, an improvement from prior year.)
- $(2,148,611) — Net Loss (For the three months ended December 31, 2023.)
- $124,715 — Cash & Cash Equivalents (As of December 31, 2024, a significant decrease from September 30, 2024.)
- $464,222 — Cash & Cash Equivalents (As of September 30, 2024.)
- $1,300,000 — Convertible Notes (Principal amount of August Notes converted into common stock.)
- $0.94 — Conversion Price (Per share for the August Notes.)
- 3,508,769 — Shares Issued (Through private placement.)
- $2,000,000 — Proceeds (From private placement.)
Key Players & Entities
- CIMG Inc. (company) — Registrant, formerly Nuzee, Inc.
- Nuzee, Inc. (company) — Former name of CIMG Inc.
- NASDAQ Stock Market LLC (regulator) — Exchange where CIMG Common Stock is registered
- Securities and Exchange Commission (regulator) — Regulatory body for the 10-Q/A filing
- DZR Tech (company) — CIMG subsidiary incorporated in Hong Kong
- Weiwin (company) — CIMG subsidiary incorporated in Florida
- Beijing Zhongyan (company) — CIMG PRC subsidiary
- Nevada (regulator) — State of incorporation for CIMG Inc.
FAQ
Why did CIMG Inc. file a 10-Q/A for the quarter ended December 31, 2024?
CIMG Inc. filed the 10-Q/A to include additional disclosures inadvertently omitted from the original filing. Specifically, it added Item 2 (Management's Discussion and Analysis of Financial Condition and Results of Operations), Item 3 (Quantitative and Qualitative Disclosures About Market Risk), and Item 4 (Controls and Procedures) of Part I.
What was CIMG Inc.'s net revenue for the three months ended December 31, 2024?
CIMG Inc.'s net revenue for the three months ended December 31, 2024, was $22,853. This represents a substantial decrease of 97.6% compared to $965,932 for the same period in 2023.
How did CIMG Inc.'s net loss change year-over-year for the quarter ended December 31, 2024?
CIMG Inc.'s net loss improved slightly, decreasing to $(1,536,249) for the three months ended December 31, 2024, from $(2,148,611) for the same period in 2023. This improvement was primarily driven by a reduction in operating expenses.
What is CIMG Inc.'s cash position as of December 31, 2024?
As of December 31, 2024, CIMG Inc. had cash and cash equivalents of $124,715. This is a significant decline from $464,222 reported as of September 30, 2024.
What strategic changes is CIMG Inc. undertaking?
CIMG Inc., formerly focused on specialty coffee, is now expanding its sales and distribution channels in Asia to encompass a broader range of consumer food and beverage products. This expansion is supported by an online sales platform utilizing a natural language search function.
Did CIMG Inc. complete any significant financing activities during the quarter?
Yes, CIMG Inc. completed the conversion of $1,300,000 in August Notes into common stock at a conversion price of $0.94 per share on October 31, 2024. Additionally, the company issued 3,508,769 shares through a private placement, generating $2,000,000 in proceeds.
What is CIMG Inc.'s current status regarding its ability to continue as a going concern?
Management has concluded that no substantial doubt exists regarding CIMG Inc.'s ability to continue as a going concern for at least one year from the date of issuance of these consolidated financial statements. However, the company's forward-looking statements indicate an expectation to need additional capital beyond the next three months.
How many shares of CIMG Inc. Common Stock were outstanding as of August 19, 2025?
As of August 19, 2025, there were 36,397,418 shares of CIMG Inc.'s Common Stock outstanding. This is a significant increase from 10,739,800 shares outstanding as of December 31, 2024.
What was the change in CIMG Inc.'s total current liabilities?
CIMG Inc.'s total current liabilities decreased substantially from $6,238,323 as of September 30, 2024, to $3,640,244 as of December 31, 2024. This reduction was primarily due to a $1,486,996 repayment of short-term loans and the conversion of convertible notes.
What was the basic and diluted loss per common share for CIMG Inc. for the quarter ended December 31, 2024?
The basic and diluted loss per common share for CIMG Inc. for the three months ended December 31, 2024, was $(0.17). This is an improvement from $(1.84) for the same period in 2023, despite the increased number of outstanding shares.
Risk Factors
- Severe Revenue Decline [high — financial]: Net revenue dropped by 97.6% from $965,932 in Q4 2023 to $22,853 in Q4 2024. This drastic reduction poses a significant threat to the company's ongoing operations and ability to generate future income.
- Dwindling Cash Reserves [high — financial]: Cash and cash equivalents decreased from $464,222 as of September 30, 2024, to $124,715 as of December 31, 2024. This represents a substantial burn rate and raises concerns about the company's short-term liquidity.
- High Leverage and Debt Conversion [medium — financial]: While total current liabilities decreased from $6,238,323 to $3,640,244, this was largely due to debt repayment and conversion of $1,300,000 in convertible notes. The company still faces the challenge of managing its debt obligations.
- Operational Viability [high — operational]: The dramatic decrease in revenue and cash suggests potential fundamental issues with the company's business model or market position. Sustaining operations with such diminished revenue is a major concern.
Industry Context
CIMG Inc. operates in a highly competitive environment where rapid technological advancements and shifting consumer demands necessitate agility. Companies in this sector often face pressure to innovate while managing significant R&D and marketing costs. The recent performance of CIMG suggests it is struggling to maintain market share or adapt to current industry dynamics, potentially due to intense competition or a lack of competitive differentiation.
Regulatory Implications
The filing of an amended 10-Q/A highlights potential deficiencies in CIMG's initial reporting processes. Investors and regulators will scrutinize the newly added disclosures (MD&A, Market Risk, Controls) for any further red flags or compliance issues. Failure to maintain adequate internal controls or accurately disclose material information could lead to SEC enforcement actions or shareholder lawsuits.
What Investors Should Do
- Monitor cash burn rate closely: With cash falling to $124,715, investors should track subsequent filings to ensure the company can sustain operations.
- Analyze the MD&A for reasons behind revenue collapse: Understanding the specific drivers of the 97.6% revenue decline is critical for assessing future prospects.
- Evaluate the impact of dilution: The recent private placement and convertible note conversion have diluted existing shareholders; assess if the capital raised justifies the dilution.
- Assess the adequacy of controls: Review the newly disclosed 'Controls and Procedures' section for any weaknesses that could impact financial reporting reliability.
Key Dates
- 2024-12-31: Quarter End — Reporting period for the 10-Q/A, showing a drastic decline in revenue and cash.
- 2024-10-31: Convertible Note Conversion — CIMG converted $1,300,000 in August Notes into common stock at $0.94 per share, reducing debt but diluting existing shareholders.
- 2024-10-31: Private Placement — CIMG issued 3,508,769 shares, raising $2,000,000. This provided much-needed capital but also diluted shareholders.
- 2024-09-30: Prior Quarter End — Benchmark for cash position, which stood at $464,222, highlighting the significant cash burn in the subsequent quarter.
Glossary
- 10-Q/A
- An amended quarterly report filed with the SEC, used to correct or supplement previously filed information. (This filing is an amendment, indicating CIMG is correcting or adding previously omitted disclosures.)
- Management's Discussion and Analysis (MD&A)
- A section in SEC filings where management provides an overview of the company's financial condition and results of operations. (This was an omitted disclosure that CIMG has now included, providing crucial context for the financial performance.)
- Market Risk Disclosures
- Information about the potential risks arising from market fluctuations, such as interest rate or currency changes. (Another omitted disclosure now included, which may shed light on external factors impacting CIMG.)
- Controls and Procedures
- Internal controls designed to ensure accurate financial reporting and operational efficiency. (This omitted disclosure, now included, is important for assessing the reliability of CIMG's financial statements.)
- Convertible Notes
- Debt instruments that can be converted into a predetermined amount of equity (stock) in the issuing company. (CIMG converted $1,300,000 of these notes, impacting its debt and equity structure.)
Year-Over-Year Comparison
Compared to the prior year's Q4, CIMG Inc. has experienced a catastrophic decline in net revenue, plummeting by 97.6% from $965,932 to $22,853. While the net loss has narrowed from $(2,148,611) to $(1,536,249) due to reduced operating expenses, this improvement is overshadowed by the severe revenue contraction. Gross margin has also significantly decreased from approximately 12.9% ($124,534/$965,932) to 67.7% ($15,479/$22,853), indicating a severe drop in profitability per dollar of sales. Cash reserves have been depleted by over 73% in the quarter, raising serious liquidity concerns.
Filing Stats: 4,479 words · 18 min read · ~15 pages · Grade level 16.7 · Accepted 2025-11-18 16:06:14
Key Financial Figures
- $0.00001 — nge on which registered Common Stock, $0.00001 par value IMG The NASDAQ Stock Mark
Filing Documents
- form10-qa.htm (10-Q/A) — 989KB
- ex31-1.htm (EX-31.1) — 14KB
- ex31-2.htm (EX-31.2) — 14KB
- ex32.htm (EX-32) — 10KB
- form10-qa_001.jpg (GRAPHIC) — 99KB
- 0001493152-25-024063.txt ( ) — 6032KB
- img-20241231.xsd (EX-101.SCH) — 42KB
- img-20241231_cal.xml (EX-101.CAL) — 62KB
- img-20241231_def.xml (EX-101.DEF) — 125KB
- img-20241231_lab.xml (EX-101.LAB) — 410KB
- img-20241231_pre.xml (EX-101.PRE) — 303KB
- form10-qa_htm.xml (XML) — 958KB
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 23 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 29 Item 4.
Controls and Procedures
Controls and Procedures 29 PART II. OTHER INFORMATION 30 Item 1. Legal Proceedings 30 Item 1A. Risk Factors 30 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 30 Item 3. Defaults Upon Senior Securities 30 Item 4. Mine Safety Disclosures 30 Item 5. Other Information 30 Item 6. Exhibits 31
SIGNATURES
SIGNATURES 32 2 Cautionary Note Regarding Forward-Looking Statements This Quarterly Report on Form 10-Q and the documents incorporated by reference contain "forward-looking statements", within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, which include information relating to future events, future financial performance, strategies, expectations, competitive environment, regulation and availability of resources. These forward-looking matters will or will not have a material adverse effect on our consolidated financial position, results of operations or liquidity; statements concerning projections, predictions, expectations, estimates or forecasts as to our business, financial and operating results and future economic performance; and statements of management's goals and objectives and other similar expressions concerning matters that are not historical facts. Words such as "may," "should," "could," "would," "predicts," "potential," "continue," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," and similar expressions, as well as statements in future tense, identify forward-looking statements. Forward-looking times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events and are by the forward-looking statements. Important factors that could cause such differences include, but are not limited to: our plans